After 50 Years of Chemo, One Biotech Could Lead the Next Cancer Breakthrough

For decades, toxic chemotherapy defined cancer care. This biotech's innovative approach could finally change that. With early results showing precision without poison, this story is one investors will want to see early.

Clearmind Medicine (CMND) Stock Soars Thursday: What's Going On?

Evette Mitkov
November 13, 2025

Clearmind Medicine Inc (NASDAQ:CMND) shares are trading higher on Thursday. The company reported that Hadassah Medical Center in Jerusalem has given its final approval for an ongoing Phase 1/2a clinical trial, which is assessing CMND-100’s potential to treat alcohol use disorder (AUD).

  • CMND is delivering impressive returns. See what is driving the move here.

What To Know: The clinical-stage biotech company’s CMND-100 is a proprietary MEAI-based oral drug candidate. Clearmind received final approval for its ongoing Phase 1/2a clinical trial evaluating CMND-100 for the treatment of AUD.

The first cohort treatment of Clearmind’s clinical trial was successfully completed. The approval enables Hadassah Medical Center to join the company’s clinical trial.

The Yale School of Medicine’s Department of Psychiatry, Johns Hopkins University School of Medicine, and Israel’s Tel Aviv Sourasky Medical Center are among the other institutions taking part in the trial. The study at Hadassah-University Medical Center will be supervised by Joseph Caraco, the director of the clinical pharmacology unit in the medical department.

The Phase 1/2a clinical trial is a multinational, multi-center investigation intended to assess the pharmacokinetic profile, safety and tolerability of CMND-100. Additionally, the study will gauge its initial success in lowering alcohol consumption and cravings in patients with alcohol use disorder.

According to the World Health Organization, AUD causes 4.7% of all deaths globally; Clearmind’s trial aims to address this issue. With the goal of providing a ground-breaking solution for those impacted by AUD and their families, the company expects to make additional steps in patient enrollment and data collection throughout its clinical site.

CMND Price Action: Clearmind shares were up 18.05%, trading at approximately 37 cents at the time of publication on Thursday, according to Benzinga Pro. Operating in the pharmaceutical industry, Clearmind Medicine’s 52-week range shows notable volatility, peaking at $2.18, indicating a high level of investor speculation or interest in the company’s potential for growth.

Read Next:

  • Why LightPath Technologies Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket

Image: Bigc Studio/Shutterstock.com

Continue Reading...

Popular

Tradr Expands Leveraged Lineup With 4 New Single-Stock ETFs Targeting AI Infrastructure Firms

The new ETFs offer 2x exposure to Bloom Energy, Celestica, NANO Nuclear Energy, and Synopsys—each linked to America's expanding AI infrastructure.

Serve Robotics Shares Skid: What's Going On?

Serve Robotics Inc (NASDAQ:SERV) shares are trading lower on Thursday. The company disclosed its financial results for the third quarter.

This Overlooked Memecoin Is Showing Early Breakout Signals - Ad

We've been tracking one small memecoin that checks all the boxes: strong on-chain signals, real traction, and an entry point that could offer serious upside. It's not on many radars yet-but that could change fast.

Gilead's One-Pill HIV Treatment Shows Promise In Late-Stage Trial

Gilead's Phase 3 ARTISTRY-1 trial shows its single-tablet HIV regimen of bictegravir and lenacapavir matches the efficacy and safety of current therapy.

AI In Finance: How Autonomous Agents Are Changing Fintech

Benzinga hosts a panel titled "AI In Finance: How Autonomous Agents are Changing Financial Services" examining the use of AI in fintech.

Buy This Stock Tomorrow? - Ad

A renowned former hedge fund manager - friends to some of the biggest investors in the world - just released a new list of his favorite AI stocks... and not a single Magnificent 7 name made the cut. Instead, an AI stock you've likely never heard of just flagged as "near-perfect" in his new investing scoring system.

Zohran Mamdani Says No More Thanking Veterans Today, Forgetting Tomorrow — Trump, Obama And Others Express Gratitude For Service

America's top political and tech leaders — including Donald Trump, Barack Obama, Tim Cook, and Sundar Pichai — marked Veterans Day 2025 with tributes honoring the courage and sacrifice of U.S. service members.

Turkey in talks with Qatar and Oman to buy used Eurofighter jets, Erdogan says

ANKARA, Turkey (AP) — Turkey is negotiating with Qatar and Oman to acquire used Eurofighter Typhoon fighter jets as part of its effort to bolster its air force capabilities, President said in comments released Friday.

The K7 Is Changing the Economics of Security - Ad

$65-an-hour guards can't compete with a $15-an-hour AI machine that never sleeps. The K7 delivers nonstop protection and smarter analytics that improve with every patrol.

Job Market Pessimism Among Americans Hovers At Record Highs: 'Fears of Unemployment Have Never Been This Elevated'

Job market pessimism among Americans has reached alarming levels, with a dramatic surge in fears about unemployment and job security in recent weeks.

"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad

George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.

The Real Reason This Analyst Still Calls Nebius His Favorite Neocloud Player

Nebius Group (NASDAQ: NBIS) reported strong Q3 results, boosting capacity & revenue guidance through 2026. Analyst reiterated Buy rating.

Huntington Bancshares buying Cadence Bank in $7.4 billion all-stock deal

Huntington Bancshares is buying regional bank Cadence Bank in an all-stock deal valued at $7.4 billion that will strengthen its position across the Southern U.S.

A Low-Profile Memecoin Is Quietly Gaining Serious Momentum - Ad

While everyone's watching the big-name coins, a lesser-known memecoin is gathering speed. With unique utility, a growing user base, and strong chart signals, our research team believes this could be a breakout waiting to happen.

This Undervalued Biotech Might Have Just Proven Its Star Drug's Staying Power

Apellis reports five-year Syfovre data showing up to 31% slower GA lesion growth, reinforcing strong long-term efficacy and analyst optimism.

Another Gold High? Here's the Move Wall Street Is Missing ... - Ad

Gold just surged past $4,200, up 45% in a year - but Sean Brodrick says $6,900 could be next. History shows when gold booms, one hidden play has delivered far bigger gains - 21x, 49x, even 1,386x. The same strategy once handed 26,000% profits. And Sean says it's back on the table now.

Mark Zuckerberg's Patience 'Ran Out': Hyperbolic CTO Says Yann LeCun's Meta Exit Was Inevitable After $15 Billion Alexandr Wang Deal

Hyperbolic CTO Yuchen Jin claimed that Yann LeCun's reported exit from Meta was inevitable after Mark Zuckerberg's $15 billion acquisition of Alexandr Wang, signaling a power shift in Meta's AI strategy from long-term research to aggressive, product-driven innovation.

Jim Cramer: Chipotle Is 'Too Expensive,' Buy This Plane Maker

On "Mad Money," Cramer discusses Henry Schein, Bloom Energy, Tyler Technologies, Boeing and Chipotle Mexican Grill.

The New Gold Trade Dominating on Wall Street - Ad

Wall Street has been making headlines lately for piling into gold. According to Dr. David Eifrig, the gold bull run is just getting started. He says you should move your money to his No. 1 gold stock immediately (not a miner or ETF but it has 1,000% upside potential.)

China's Singles' Day online shopping bonanza's sales slow as shoppers opt for more affordable deals

BANGKOK (AP) — Sales during China's largest online shopping festival, Singles' Day, jumped almost 18% from a year earlier but the pace of growth slowed as bargain hunters opted for more affordable deals.

America's Next Security Revolution Has Begun - Ad

Built for endurance, powered by AI, and proven in the field, the K7 is redefining protection for ports, energy hubs, and cities across the nation. The rollout is already underway.

Visa Launches Stablecoin Payouts For The Gig Economy As Traders Eye $343

Visa Inc. (NYSE:V) is shaking up digital payments with a new pilot program that lets creators, freelancers, and gig workers receive instant USDC stablecoin payouts

AMD, Oklo, AppLovin Corp, Viking Therapeutics And Novo Nordisk: Why These 5 Stocks Are On Investors' Radars Today

Major U.S. indices closed mixed on Tuesday, with the Dow Jones Industrial Average climbing 1.2% to 47,927.96 and the S&P 500 inching up 0.2% to 6,846.61.

Why Wall Street Is Piling Into the "Debasement Trade" - Ad

Wall Street has been making headlines lately for piling into a strange new money move. What they've dubbed the "Debasement Trade"... And it could affect you and your money in a MAJOR way. Dr. David Eifrig's latest warning deserves your attention.

A medley of tech gifts for everyone on your holiday shopping list

NEW YORK (AP) — It's the most wonderful time of the year, unless you want to find the perfect gifts for .

What to know as the annual sign-up window for health insurance arrives

Higher prices, less help and all hang over health insurance markets as shoppers start looking for coverage this week.

After 50 Years of Chemo, One Biotech Could Lead the Next Cancer Breakthrough - Ad

For decades, toxic chemotherapy defined cancer care. This biotech's innovative approach could finally change that. With early results showing precision without poison, this story is one investors will want to see early.

Court Blocks Trump's SNAP Reductions, But Stricter Eligibility Rules Begin

New work requirements for SNAP begin Saturday, but benefits may not be issued through November due to the government shutdown.

Dave Ramsey Reveals Why Millionaires Crush Mortgages Early

Dave Ramsey advises buying a home with cash, citing his firm's survey of millionaires who often retire their mortgages in about 10 years.

This Overlooked Memecoin Is Showing Early Breakout Signals - Ad

We've been tracking one small memecoin that checks all the boxes: strong on-chain signals, real traction, and an entry point that could offer serious upside. It's not on many radars yet-but that could change fast.

Buy This Stock Tomorrow? - Ad

A renowned former hedge fund manager - friends to some of the biggest investors in the world - just released a new list of his favorite AI stocks... and not a single Magnificent 7 name made the cut. Instead, an AI stock you've likely never heard of just flagged as "near-perfect" in his new investing scoring system.

NTSB says FAA was wrong not to require inspections of Learjet landing gear after Arizona crash

The National Transportation Safety Board wants the owners of nearly 2,000 Learjets — which have long been associated with the rich and famous — to urgently inspect their landing gear to make sure they won’t collapse as happened in a fatal crash in February involving a private jet owned by Mötley Crüe singer Vince Neil.

The K7 Is Changing the Economics of Security - Ad

$65-an-hour guards can't compete with a $15-an-hour AI machine that never sleeps. The K7 delivers nonstop protection and smarter analytics that improve with every patrol.

Traders Love This Time Of Year For Broadcom — Here's Why It Rarely Fails

Broadcom stock has gained in 14 of the last 16 mid-November to mid-December periods, with an average return of 8.9%.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright activatrade.ca
Privacy Policy | Terms of Service